Caleb Graham
Overview
Explore the profile of Caleb Graham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghafil C, Park C, Yu J, Drake A, Sundaram S, Thiele L, et al.
J Trauma Acute Care Surg
. 2023 Nov;
96(5):757-762.
PMID: 37962213
Background: The use of anticoagulation therapy (ACT) in trauma patients during the postinjury period presents a challenge given the increased risk of hemorrhage. Guidelines regarding whether and when to initiate...
2.
Isayeva Waldrop T, Graham C, Gard W, Ingle K, Ptacek T, Nguyen N, et al.
Front Bioeng Biotechnol
. 2023 Mar;
11:1101622.
PMID: 36873372
Cardiovascular events are the primary cause of death among dialysis patients. While arteriovenous fistulas (AVFs) are the access of choice for hemodialysis patients, AVF creation can lead to a volume...
3.
Donoghue L, Graham C, Sethu P
Cells Tissues Organs
. 2022 May;
212(4):352-362.
PMID: 35640546
The heart is a dynamic organ, and the cardiac tissue experiences changes in pressure and stretch during the cardiac cycle. Existing cell culture and animal models are limited in their...
4.
Budhathoki S, Graham C, Sethu P, Kannappan R
Cells Tissues Organs
. 2021 Aug;
211(3):348-359.
PMID: 34365455
Due to the rapidly growing number of older people worldwide and the concomitant increase in cardiovascular complications, there is an urgent need for age-related cardiac disease modeling and drug screening...
5.
Donoghue L, Nguyen K, Graham C, Sethu P
Micromachines (Basel)
. 2021 Feb;
12(2).
PMID: 33525451
Tissue chips (TCs) and microphysiological systems (MPSs) that incorporate human cells are novel platforms to model disease and screen drugs and provide an alternative to traditional animal studies. This review...
6.
Oweida A, Lennon S, Calame D, Korpela S, Bhatia S, Sharma J, et al.
Oncoimmunology
. 2017 Nov;
6(10):e1356153.
PMID: 29123967
Immunotherapy clinical trials targeting the programmed-death ligand axis (PD-1/PD-L1) show that most head and neck squamous cell carcinoma (HNSCC) patients are resistant to PD-1/PD-L1 inhibition. We investigated whether local radiation...